Belle Brands has acquired VEGAMOUR, a biotech-powered hair longevity company, for an undisclosed amount. The transaction brings the plant-derived exosome and liposomal delivery technology specialist under the ownership of Belle Brands, which will now oversee VEGAMOUR’s operations and product portfolio.
VEGAMOUR develops clean, clinically proven hair wellness solutions designed to support the full hair life cycle. Its formulations avoid synthetic hormones and harsh chemicals, instead using plant-derived exosome technology and liposomal delivery systems to target the hair’s anagen phase, reduce shedding, and maintain scalp balance. Belle Brands, the acquiring entity, is adding this science-led platform to its existing portfolio, which focuses on consumer wellness and personal care categories.
The acquisition is driven by a strategic fit between Belle Brands’ distribution capabilities and VEGAMOUR’s specialized R&D in regenerative hair care. Belle Brands gains entry into the premium hair longevity segment, a niche that has grown as consumers seek alternatives to hormone-based treatments. For VEGAMOUR, the deal provides access to broader retail and marketing infrastructure, which could accelerate its reach beyond its current direct-to-consumer base. The transaction also allows Belle Brands to leverage VEGAMOUR’s proprietary delivery technology across adjacent product lines.
No financial terms were disclosed, and the companies have not detailed integration timelines. The combined entity is expected to focus on scaling VEGAMOUR’s existing product range while exploring new applications for its exosome-based platform. Operational leadership and product development teams are anticipated to remain in place to preserve the brand’s scientific positioning. The acquisition positions Belle Brands to compete more directly in the science-backed beauty space, where efficacy and clean ingredient profiles are becoming primary purchase drivers.